Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease.
Pontali E, Volpi S, Antonucci G, Castellaneta M, Buzzi D, Tricerri F, Angelelli A, Caorsi R, Feasi M, Calautti F, Castagnola E, Rollandi GA, Ravelli A, Cassola G, Gattorno M.
Pontali E, et al. Among authors: rollandi ga.
J Allergy Clin Immunol. 2020 Jul;146(1):213-215. doi: 10.1016/j.jaci.2020.05.002. Epub 2020 May 11.
J Allergy Clin Immunol. 2020.
PMID: 32437739
Free PMC article.
No abstract available.